Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.41.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.41.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
BF.41.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
BF.41.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BF.41.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.41.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.41.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.41.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.41.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.41.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.41.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.41.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.41.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.41.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.41.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BF.41.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BF.41.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BF.41.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.41.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BF.41.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BF.41.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BF.41.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.41.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BF.41.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BF.41.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.41.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.41.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.41.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BF.41.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.41.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.41.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.41.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.41.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BF.41.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BF.41.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.41.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BF.5ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BF.5ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
BF.5ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-6007.95France
BF.5ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
BF.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.5ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-1313China
BF.5ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-3270.88China
BF.5ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BF.5ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BF.5ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BF.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BF.5ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BF.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used